Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.

Izutsu K, Minami Y, Fukuhara N, Terui Y, Jo T, Yamamoto G, Ishikawa T, Kobayashi T, Kiguchi T, Nagai H, Ohtsu T, Kalambakas S, Fustier P, Midorikawa S, Tobinai K.

Int J Hematol. 2019 Dec 19. doi: 10.1007/s12185-019-02802-y. [Epub ahead of print]

PMID:
31858429
2.

Harms of Pediatric Thyroid Cancer Overdiagnosis.

Murakami M, Midorikawa S, Ohtsuru A.

JAMA Otolaryngol Head Neck Surg. 2019 Oct 17. doi: 10.1001/jamaoto.2019.3051. [Epub ahead of print] No abstract available.

PMID:
31621800
3.

Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.

Midorikawa S, Murakami M, Ohtsuru A.

Cancer. 2019 Nov 15;125(22):4108-4109. doi: 10.1002/cncr.32426. Epub 2019 Jul 29. No abstract available.

PMID:
31355909
4.

External Radiation Dose, Obesity, and Risk of Childhood Thyroid Cancer After the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey.

Ohira T, Ohtsuru A, Midorikawa S, Takahashi H, Yasumura S, Suzuki S, Matsuzuka T, Shimura H, Ishikawa T, Sakai A, Suzuki S, Yamashita S, Yokoya S, Tanigawa K, Ohto H, Kamiya K; Fukushima Health Management Survey group.

Epidemiology. 2019 Nov;30(6):853-860. doi: 10.1097/EDE.0000000000001058.

PMID:
31259849
5.

Factors influencing the proportion of non-examinees in the Fukushima Health Management Survey for childhood and adolescent thyroid cancer: Results from the baseline survey.

Takahashi K, Takahashi H, Nakaya T, Yasumura S, Ohira T, Ohto H, Ohtsuru A, Midorikawa S, Suzuki S, Shimura H, Yamashita S, Tanigawa K, Kamiya K.

J Epidemiol. 2019 Jun 15. doi: 10.2188/jea.JE20180247. [Epub ahead of print]

6.

Spatial analysis of the geographical distribution of thyroid cancer cases from the first-round thyroid ultrasound examination in Fukushima Prefecture.

Nakaya T, Takahashi K, Takahashi H, Yasumura S, Ohira T, Ohto H, Ohtsuru A, Midorikawa S, Suzuki S, Shimura H, Yamashita S, Tanigawa K, Kamiya K.

Sci Rep. 2018 Dec 5;8(1):17661. doi: 10.1038/s41598-018-35971-7.

7.

Incidence of Thyroid Cancer Among Children and Young Adults in Fukushima, Japan, Screened With 2 Rounds of Ultrasonography Within 5 Years of the 2011 Fukushima Daiichi Nuclear Power Station Accident.

Ohtsuru A, Midorikawa S, Ohira T, Suzuki S, Takahashi H, Murakami M, Shimura H, Matsuzuka T, Yasumura S, Suzuki SI, Yokoya S, Hashimoto Y, Sakai A, Ohto H, Yamashita S, Tanigawa K, Kamiya K.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):4-11. doi: 10.1001/jamaoto.2018.3121.

8.

Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomers.

Murakami K, Yoshioka T, Horii S, Hanaki M, Midorikawa S, Taniwaki S, Gunji H, Akagi KI, Kawase T, Hirose K, Irie K.

Chem Commun (Camb). 2018 Jun 14;54(49):6272-6275. doi: 10.1039/c8cc03230k.

PMID:
29850758
9.

Mental health of nurses after the Fukushima complex disaster: a narrative review.

Nukui H, Midorikawa S, Murakami M, Maeda M, Ohtsuru A.

J Radiat Res. 2018 Apr 1;59(suppl_2):ii108-ii113. doi: 10.1093/jrr/rry023. Review.

10.

Associations Between Childhood Thyroid Cancer and External Radiation Dose After the Fukushima Daiichi Nuclear Power Plant Accident.

Ohira T, Takahashi H, Yasumura S, Ohtsuru A, Midorikawa S, Suzuki S, Matsuzuka T, Shimura H, Ishikawa T, Sakai A, Yamashita S, Tanigawa K, Ohto H, Kamiya K, Suzuki S; Fukushima Health Management Survey Group.

Epidemiology. 2018 Jul;29(4):e32-e34. doi: 10.1097/EDE.0000000000000839. No abstract available.

PMID:
29634592
11.

Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer-progression model based on the National Cancer Registry: Application to the first-round thyroid examination of the Fukushima Health Management Survey.

Takahashi H, Takahashi K, Shimura H, Yasumura S, Suzuki S, Ohtsuru A, Midorikawa S, Ohira T, Ohto H, Yamashita S, Kamiya K.

Medicine (Baltimore). 2017 Dec;96(48):e8631. doi: 10.1097/MD.0000000000008631.

12.

Findings of Thyroid Ultrasound Examination Within 3 Years After the Fukushima Nuclear Power Plant Accident: The Fukushima Health Management Survey.

Shimura H, Sobue T, Takahashi H, Yasumura S, Ohira T, Ohtsuru A, Midorikawa S, Suzuki S, Fukushima T, Suzuki S, Yamashita S, Ohto H; Thyroid Examination Unit of the Radiation Medical Center for the Fukushima Health Management Survey Group.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):861-869. doi: 10.1210/jc.2017-01603.

PMID:
29253182
13.

[Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study].

Ando K, Chou T, Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Okamoto S, Otsuka M, Matsumoto M, Iida S, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Terui Y.

Rinsho Ketsueki. 2017;58(11):2219-2226. doi: 10.11406/rinketsu.58.2219. Japanese.

PMID:
29212972
14.

Comparative Analysis of the Growth Pattern of Thyroid Cancer in Young Patients Screened by Ultrasonography in Japan After a Nuclear Accident: The Fukushima Health Management Survey.

Midorikawa S, Ohtsuru A, Murakami M, Takahashi H, Suzuki S, Matsuzuka T, Shimura H, Ohira T, Suzuki SI, Yasumura S, Yamashita S, Ohto H, Tanigawa K, Kamiya K.

JAMA Otolaryngol Head Neck Surg. 2018 Jan 1;144(1):57-63. doi: 10.1001/jamaoto.2017.2133.

15.

Prevalence and Characterization of Thyroid Hemiagenesis in Japan: The Fukushima Health Management Survey.

Suzuki S, Midorikawa S, Matsuzuka T, Fukushima T, Ito Y, Shimura H, Takahashi H, Ohira T, Ohtsuru A, Abe M, Suzuki S, Yamashita S.

Thyroid. 2017 Aug;27(8):1011-1016. doi: 10.1089/thy.2016.0662.

16.

Internal validation of a scoring system to evaluate the probability of ureteral stones: The CHOKAI score.

Fukuhara H, Ichiyanagi O, Midorikawa S, Kakizaki H, Kaneko H, Tsuchiya N.

Am J Emerg Med. 2017 Dec;35(12):1859-1866. doi: 10.1016/j.ajem.2017.06.023. Epub 2017 Jun 13.

17.

Mental Health and Related Factors of Hospital Nurses.

Nukui H, Murakami M, Midorikawa S, Suenaga M, Rokkaku Y, Yabe H, Ohtsuru A.

Asia Pac J Public Health. 2017 Mar;29(2_suppl):161S-170S. doi: 10.1177/1010539516682589.

PMID:
28330404
18.

Psychosocial Issues Related to Thyroid Examination After a Radiation Disaster.

Midorikawa S, Tanigawa K, Suzuki S, Ohtsuru A.

Asia Pac J Public Health. 2017 Mar;29(2_suppl):63S-73S. doi: 10.1177/1010539516686164. Review.

PMID:
28330396
19.

The Authors Respond.

Takahashi H, Ohira T, Ohtsuru A, Shimura H, Tsuboi K, Yasumura S, Tanigawa K, Midorikawa S, Suzuki S.

Epidemiology. 2017 Jan;28(1):e5-e6. No abstract available.

PMID:
27902534
20.

Semisynthesis and Structure-Activity Studies of Uncarinic Acid C Isolated from Uncaria rhynchophylla as a Specific Inhibitor of the Nucleation Phase in Amyloid β42 Aggregation.

Yoshioka T, Murakami K, Ido K, Hanaki M, Yamaguchi K, Midorikawa S, Taniwaki S, Gunji H, Irie K.

J Nat Prod. 2016 Oct 28;79(10):2521-2529. Epub 2016 Oct 4.

PMID:
27700077
21.

Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus.

Hirai H, Midorikawa S, Suzuki S, Sasano H, Watanabe T, Satoh H.

Intern Med. 2016;55(20):2985-2991. Epub 2016 Oct 15.

22.

Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.

Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, Moriuchi Y, Jo T, Ishizawa K, Tobinai K, Tsukasaki K, Ito S, Yoshimitsu M, Otsuka M, Ogura M, Midorikawa S, Ruiz W, Ohtsu T.

J Clin Oncol. 2016 Dec;34(34):4086-4093. Epub 2016 Sep 30.

PMID:
27621400
23.

[Primary Pituitary Malignant Lymphoma that was Difficult to Differentiate from Nonfunctioning Pituitary Adenoma:A Case Report].

Murakami Y, Sato T, Jinguji S, Kishida Y, Watanabe T, Suzuki O, Ikeda K, Homma M, Midorikawa S, Saito K.

No Shinkei Geka. 2016 Sep;44(9):779-84. doi: 10.11477/mf.1436203376. Japanese.

PMID:
27605481
24.

Comparison of childhood thyroid cancer prevalence among 3 areas based on external radiation dose after the Fukushima Daiichi nuclear power plant accident: The Fukushima health management survey.

Ohira T, Takahashi H, Yasumura S, Ohtsuru A, Midorikawa S, Suzuki S, Fukushima T, Shimura H, Ishikawa T, Sakai A, Yamashita S, Tanigawa K, Ohto H, Abe M, Suzuki S; Fukushima Health Management Survey Group.

Medicine (Baltimore). 2016 Aug;95(35):e4472. doi: 10.1097/MD.0000000000004472.

25.

Explanatory Meetings on Thyroid Examination for the "Fukushima Health Management Survey" after the Great East Japan Earthquake: Reduction of Anxiety and Improvement of Comprehension.

Hino Y, Murakami M, Midorikawa S, Ohtsuru A, Suzuki S, Tsuboi K, Ohira T.

Tohoku J Exp Med. 2016 Aug;239(4):333-43. doi: 10.1620/tjem.239.333.

26.

[Human Resource Development for Thyroid Ultrasound Examination Program in Fukushima].

Sato A, Shimura H, Hakoiwa T, Sakagami T, Ohishi M, Sato Y, Sakuma N, Midorikawa S, Suzuki S, Ohtsuru A, Suzuki S.

Rinsho Byori. 2016 Jan;64(1):80-4. Review. Japanese.

PMID:
27192802
27.

After Fukushima: Addressing anxiety.

Midorikawa S, Suzuki S, Ohtsuru A.

Science. 2016 May 6;352(6286):666-7. doi: 10.1126/science.352.6286.666-c. No abstract available.

PMID:
27151857
28.

Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years After the Fukushima Daiichi Nuclear Power Plant Accident.

Suzuki S, Suzuki S, Fukushima T, Midorikawa S, Shimura H, Matsuzuka T, Ishikawa T, Takahashi H, Ohtsuru A, Sakai A, Hosoya M, Yasumura S, Nollet KE, Ohira T, Ohto H, Abe M, Kamiya K, Yamashita S.

Thyroid. 2016 Jun;26(6):843-51. doi: 10.1089/thy.2015.0564. Epub 2016 May 10.

PMID:
27098220
29.

Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.

Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota-Nakayama F, Oki Y, Baba S, Midorikawa S, Morimoto R, Satoh F, Sasano H.

Hum Pathol. 2016 Jul;53:41-50. doi: 10.1016/j.humpath.2015.10.017. Epub 2016 Mar 7.

PMID:
26980031
30.

Inappropriate Suppression of Thyrotropin Concentrations in Young Patients with Thyroid Nodules Including Thyroid Cancer: The Fukushima Health Management Survey.

Suzuki S, Nakamura I, Suzuki S, Ohkouchi C, Mizunuma H, Midorikawa S, Fukushima T, Ito Y, Shimura H, Ohira T, Matsuzuka T, Ohtsuru A, Abe M, Yamashita S, Suzuki S.

Thyroid. 2016 May;26(5):717-25. doi: 10.1089/thy.2015.0499.

PMID:
26971545
31.

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.

Ogura M, Imaizumi Y, Uike N, Asou N, Utsunomiya A, Uchida T, Aoki T, Tsukasaki K, Taguchi J, Choi I, Maruyama D, Nosaka K, Chen N, Midorikawa S, Ohtsu T, Tobinai K.

Lancet Haematol. 2016 Mar;3(3):e107-18. doi: 10.1016/S2352-3026(15)00284-7. Epub 2016 Feb 12.

PMID:
26947199
32.

The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima [Rapid Communication].

Suzuki S, Yamashita S, Fukushima T, Nakano K, Midorikawa S, Ohtsuru A, Yasumura S, Hosoya M, Kamiya K, Shimura H, Suzuki S, Nakamura I, Abe M.

Endocr J. 2016;63(3):315-21. doi: 10.1507/endocrj.EJ15-0726. Epub 2016 Feb 27.

33.

Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study.

Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Ogawa Y, Shimizu T, Otsuka M, Matsumoto M, Iida S, Terui Y, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Chou T.

Cancer Sci. 2016 May;107(5):653-8. doi: 10.1111/cas.12916. Epub 2016 Mar 30.

34.

[The Cutting-edge of Medicine; Thyroid cancer and radiation].

Ohtsuru A, Midorikawa S, Sakai A, Shimura H, Suzuki S.

Nihon Naika Gakkai Zasshi. 2015 Mar 10;104(3):593-9. Japanese. No abstract available.

PMID:
26571749
35.

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma.

Matsue K, Iwasaki H, Chou T, Tobinai K, Sunami K, Ogawa Y, Kurihara M, Midorikawa S, Zaki M, Doerr T, Iida S.

Cancer Sci. 2015 Nov;106(11):1561-7. doi: 10.1111/cas.12772. Epub 2015 Nov 4.

36.

Nuclear disasters and health: lessons learned, challenges, and proposals.

Ohtsuru A, Tanigawa K, Kumagai A, Niwa O, Takamura N, Midorikawa S, Nollet K, Yamashita S, Ohto H, Chhem RK, Clarke M.

Lancet. 2015 Aug 1;386(9992):489-97. doi: 10.1016/S0140-6736(15)60994-1. Review.

PMID:
26251394
37.

Prevalence of ectopic intrathyroidal thymus in Japan: the Fukushima health management survey.

Fukushima T, Suzuki S, Ohira T, Shimura H, Midorikawa S, Ohtsuru A, Sakai A, Abe M, Yamashita S, Suzuki S; Thyroid Examination Unit of the Radiation Medical Center for the Fukushima Health Management Survey.

Thyroid. 2015 May;25(5):534-7. doi: 10.1089/thy.2014.0367. Epub 2015 Apr 7.

PMID:
25778711
38.

Thyroid ultrasound findings in a follow-up survey of children from three Japanese prefectures: Aomori, Yamanashi, and Nagasaki.

Hayashida N, Imaizumi M, Shimura H, Furuya F, Okubo N, Asari Y, Nigawara T, Midorikawa S, Kotani K, Nakaji S, Ohtsuru A, Akamizu T, Kitaoka M, Suzuki S, Taniguchi N, Yamashita S, Takamura N.

Sci Rep. 2015 Mar 12;5:9046. doi: 10.1038/srep09046.

39.

Prevalence of thyroid nodular lesions in children and adolescents.

Shimura H, Suzuki S, Fukushima T, Midorikawa S, Suzuki S, Hayashida N, Imaizumi M, Okubo N, Asari Y, Nigawara T, Furuya F, Kotani K, Nakaji S, Otsuru A, Akamizu T, Kitaoka M, Takamura N, Abe M, Ohto H, Taniguchi N, Yamashita S.

Fukushima J Med Sci. 2014;60(2):196-202. doi: 10.5387/fms.2014-28. Epub 2014 Dec 20. No abstract available.

40.

Systematic determination of thyroid volume by ultrasound examination from infancy to adolescence in Japan: the Fukushima Health Management Survey.

Suzuki S, Midorikawa S, Fukushima T, Shimura H, Ohira T, Ohtsuru A, Abe M, Shibata Y, Yamashita S, Suzuki S; Thyroid Examination Unit of the Radiation Medical Science Center for the Fukushima Health Management Survey.

Endocr J. 2015;62(3):261-8. doi: 10.1507/endocrj.EJ14-0478. Epub 2015 Jan 15.

41.

Activating transcription factor 3 (ATF3) in the human adrenal cortex: its possible involvement in aldosterone biosynthesis.

Felizola SJ, Nakamura Y, Ozawa Y, Ono Y, Morimoto R, Midorikawa S, Suzuki S, Satoh F, Sasano H.

Tohoku J Exp Med. 2014 Dec;234(4):249-54.

42.

[Discussion meeting on the clinical pearls to diagnose endocrine disorders].

Nakazato M, Doi M, Yamaguchi H, Midorikawa S, Niimi Y, Nishihara E.

Nihon Naika Gakkai Zasshi. 2014 Apr 10;103(4):940-60; quiz 961-8. Japanese. No abstract available.

PMID:
24908993
43.

Plasma free metanephrines in the diagnosis of pheochromocytoma: diagnostic accuracy and strategies for Japanese patients.

Tanaka Y, Isobe K, Ma E, Imai T, Kikumori T, Matsuda T, Maeda Y, Sakurai A, Midorikawa S, Hataya Y, Kato T, Kamide K, Ikeda Y, Okada Y, Adachi M, Yanase T, Takahashi H, Yokoyama C, Arai Y, Hashimoto K, Shimano H, Hara H, Kawakami Y, Takekoshi K.

Endocr J. 2014;61(7):667-73. Epub 2014 May 28.

45.

Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma.

Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M.

Endocr Relat Cancer. 2014 May 6;21(3):L13-6. doi: 10.1530/ERC-13-0530. Print 2014 Jun. No abstract available.

PMID:
24659481
46.

Thyroid ultrasound findings in children from three Japanese prefectures: Aomori, Yamanashi and Nagasaki.

Hayashida N, Imaizumi M, Shimura H, Okubo N, Asari Y, Nigawara T, Midorikawa S, Kotani K, Nakaji S, Otsuru A, Akamizu T, Kitaoka M, Suzuki S, Taniguchi N, Yamashita S, Takamura N; Investigation Committee for the Proportion of Thyroid Ultrasound Findings.

PLoS One. 2013 Dec 23;8(12):e83220. doi: 10.1371/journal.pone.0083220. eCollection 2013.

47.

Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders.

Felizola SJ, Nakamura Y, Arata Y, Ise K, Satoh F, Rainey WE, Midorikawa S, Suzuki S, Sasano H.

Endocr Pathol. 2014 Sep;25(3):229-35. doi: 10.1007/s12022-013-9280-9.

PMID:
24242700
48.

Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.

Felizola SJA, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H.

Mol Cell Endocrinol. 2014 Jan 25;382(1):170-177. doi: 10.1016/j.mce.2013.09.025. Epub 2013 Sep 27.

PMID:
24080311
49.

Ultrasonographic thyroid nodular findings in Japanese children.

Taniguchi N, Hayashida N, Shimura H, Okubo N, Asari Y, Nigawara T, Midorikawa S, Kotani K, Nakaji S, Imaizumi M, Ohtsuru A, Akamizu T, Kitaoka M, Suzuki S, Yamashita S, Takamura N; Investigation Committee for the Proportion of Thyroid Ultrasound Findings.

J Med Ultrason (2001). 2013 Jul;40(3):219-24. doi: 10.1007/s10396-013-0456-1. Epub 2013 May 18.

PMID:
27277239
50.

A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes.

Nomizu T, Matsuzaki M, Katagata N, Kobayashi Y, Sakuma T, Monma T, Saito M, Watanabe F, Midorikawa S, Yamaguchi Y.

Breast Cancer. 2015 Sep;22(5):557-61. doi: 10.1007/s12282-012-0432-4. Epub 2012 Dec 15.

PMID:
23242612

Supplemental Content

Loading ...
Support Center